Can home cooking be hazardous to your health? (AP)
AP - Could your kitchen at home pass a restaurant inspection?

Botox maker to pay $600M to resolve investigation (AP)

AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.

Journal editors question sale of diet pill Meridia (AP)
AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.

Benefits seen for high-risk women in ovary removal (AP)
AP - Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer, and boosts their chances of living longer, new research suggests.

Double hand transplant patient shows new hands (AP)

AP - The recipient of a rare double hand transplant says he feels "fantastic" and can wiggle fingers on both his new hands.

Study: Diet Drug Meridia May Boost Heart Risks (Time.com)
Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke

For Bonobo Males, Mom Is the Best Wingman (LiveScience.com)
LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.

Clinical Trials Update: Sept. 3, 2010 (HealthDay)
HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Sickle Cell Kids at Greater Risk of 'Swine Flu' Complications (HealthDay)
HealthDay - FRIDAY, Sept. 3 (HealthDay News) -- Children with sickle cell disease experience more life-threatening complications from the H1N1 swine flu than from seasonal flu, a new study has found.

Seniors Get Boost From Bad News About the Young (HealthDay)
HealthDay - THURSDAY, Sept. 2 (HealthDay News) -- Older people prefer to read negative news stories about the young, possibly because it makes them feel better about themselves, a new study suggests.

Bone drugs may raise risk of throat cancer (AP)
AP - People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests.

Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice (HealthDay)
HealthDay - WEDNESDAY, Sept. 1 (HealthDay News) -- A drug widely used to treat high blood sugar in type 2 diabetics may hold some promise in the prevention of tobacco-induced lung cancer, according to extremely preliminary findings in a mouse study.

Lower Risk of Surgery Than Thought for Kids With Crohn's (HealthDay)
HealthDay - FRIDAY, Sept. 3 (HealthDay News) -- The risk of bowel surgery for children with Crohn's disease is much lower than reported in previous studies, according to new findings.

Air Force: Sergeant may have exposed others to HIV (AP)
AP - The military has arrested an Air Force sergeant and accused him of having unprotected sex with partners he met at "swinger" parties in central Kansas even though he knew he was HIV positive, according to a military affidavit.

Mouse Study May Help Explain Fish Oil's Benefits (HealthDay)
HealthDay - FRIDAY, Sept. 3 (HealthDay News) -- Feeding obese mice omega-3 fatty acids reduced inflammation that can lead to diabetes, a new study finds.

Antihistamine use linked to extra pounds (Reuters)
Reuters - People who use prescription antihistamines to relieve allergy symptoms may be more likely than non-users to carry excess pounds, a new study suggests, although the significance of the connection is not yet clear.

Abbott diet drug study renews calls for U.S. ban (Reuters)
Reuters - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.